| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD.V98.4.1038 |
| P698 | PubMed publication ID | 11493449 |
| P50 | author | Jean-Pierre Cazenave | Q28606902 |
| P2093 | author name string | P Mangin | |
| F Lanza | |||
| C Ravanat | |||
| M Freund | |||
| B Nieswandt | |||
| M Kahn | |||
| M Santer | |||
| C Gachet | |||
| S Schuhler | |||
| C Strassel | |||
| S Moog | |||
| N Lenain | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Platelet glycoprotein V | Q21981124 |
| P304 | page(s) | 1038-46 | |
| P577 | publication date | 2001-08-15 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation | |
| P478 | volume | 98 |
| Q28195840 | A PLC gamma 2-independent platelet collagen aggregation requiring functional association of GPVI and integrin alpha2beta1 |
| Q36370457 | A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo |
| Q36777936 | A guide to murine platelet structure, function, assays, and genetic alterations. |
| Q46767660 | Adhesive surface determines raft composition in platelets adhered under flow |
| Q42368316 | Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance |
| Q35550212 | Antiplatelet therapy: in search of the 'magic bullet'. |
| Q38990156 | Basic mechanisms of platelet receptor shedding |
| Q55452542 | Bone Marrow Defects and Platelet Function: A Focus on MDS and CLL. |
| Q34550744 | Collagen-binding I domain integrins--what do they do? |
| Q45060959 | Differential roles of integrins alpha2beta1 and alphaIIbbeta3 in collagen and CRP-induced platelet activation |
| Q41852033 | Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens |
| Q40335934 | Dynamic force spectroscopy of glycoprotein Ib-IX and von Willebrand factor |
| Q50245168 | Evaluation of soluble glycoprotein V as an in vitro quality marker for platelet concentrates: a correlation study between in vitro platelet quality markers and the effect of storage medium |
| Q24293698 | Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V |
| Q36753593 | Future innovations in anti-platelet therapies. |
| Q92524138 | Impact of Itga2-Gp6-double collagen receptor deficient mice for bone marrow megakaryocytes and platelets |
| Q45258114 | Importance of temporal flow gradients and integrin alphaIIbbeta3 mechanotransduction for shear activation of platelets |
| Q47129210 | In response to the comment by Hechler et al.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance |
| Q46728497 | Increased soluble glycoprotein V concentration during the acute onset of unstable angina pectoris in association with chronic cigarette smoking |
| Q41525756 | Inhibition of Collagen-Induced Platelet Aggregation by the Secobutanolide Secolincomolide A from Lindera obtusiloba Blume. |
| Q28196584 | Integrin alpha IIb beta 3-dependent calcium signals regulate platelet-fibrinogen interactions under flow. Involvement of phospholipase C gamma 2 |
| Q92451388 | Is the mysterious platelet receptor GPV an unsuspected major target for platelet autoantibodies? |
| Q33384477 | Measuring soluble platelet glycoprotein VI in human plasma by ELISA. |
| Q38874473 | Model systems for platelet receptor shedding |
| Q35574825 | Novel agents for anti-platelet therapy |
| Q43166867 | Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy |
| Q38258281 | Of von Willebrand factor and platelets |
| Q54119484 | PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway. |
| Q37127000 | Platelet IκB kinase-β deficiency increases mouse arterial neointima formation via delayed glycoprotein Ibα shedding |
| Q33432917 | Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond |
| Q36230859 | Platelets in atherothrombosis: lessons from mouse models |
| Q35119417 | Platelets in hemostasis and thrombosis: role of integrins and their ligands. |
| Q38206848 | Primary haemostasis: newer insights. |
| Q36230863 | Receptors, rafts, and microvesicles in thrombosis and inflammation |
| Q44482191 | Signaling role for phospholipase C gamma 2 in platelet glycoprotein Ib alpha calcium flux and cytoskeletal reorganization. Involvement of a pathway distinct from FcR gamma chain and Fc gamma RIIA. |
| Q46677432 | Soluble glycoprotein V as a quality marker of platelet concentrates stressed by transportation |
| Q33378654 | Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis. |
| Q34200127 | Synleurin, a novel leucine-rich repeat protein that increases the intensity of pleiotropic cytokine responses |
| Q38106013 | The effects of arterial flow on platelet activation, thrombus growth, and stabilization. |
| Q35752946 | The role of collagen in thrombosis and hemostasis |
| Q34316343 | Thrombosis as an intravascular effector of innate immunity |
Search more.